Aviva
TECH icon

Aviva’s Bio-Techne TECH Stock Holding History

Aviva’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,739
Closed -$295K – 919
2025
Q2 		$295K Sell
5,739
-103,367
-95% -$5.19M ﹤0.01% 872
2025
Q1 		$6.4M Buy
109,106
+14,043
+15% +$952K 0.02% 515
2024
Q4 		$6.85M Buy
95,063
+89,289
+1,546% +$6.56M 0.02% 498
2024
Q3 		$462K Sell
5,774
-18
-0.3% -$1.35K ﹤0.01% 818
2024
Q2 		$415K Sell
5,792
-32
-0.5% -$2.35K ﹤0.01% 847
2024
Q1 		$410K Sell
5,824
-14
-0.2% -$1K ﹤0.01% 895
2023
Q4 		$450K Sell
5,838
-8,249
-59% -$543K ﹤0.01% 882
2023
Q3 		$959K Sell
14,087
-9,034
-39% -$714K ﹤0.01% 698
2023
Q2 		$1.89M Sell
23,121
-135,934
-85% -$10.9M 0.01% 624
2023
Q1 		$11.8M Buy
159,055
+125,740
+377% +$9.69M 0.05% 439
2022
Q4 		$2.76M Sell
33,315
-7,797
-19% -$619K 0.01% 675
2022
Q3 		$2.92M Sell
41,112
-26,568
-39% -$2.3M 0.02% 658
2022
Q2 		$5.87M Sell
67,680
-1,512
-2% -$142K 0.03% 547
2022
Q1 		$7.49M Buy
69,192
+6,208
+10% +$640K 0.04% 501
2021
Q4 		$8.15M Buy
62,984
+15,660
+33% +$1.92M 0.03% 455
2021
Q3 		$5.73M Buy
47,324
+26,264
+125% +$3.2M 0.03% 544
2021
Q2 		$2.37M Buy
21,060
+8,176
+63% +$861K 0.01% 739
2021
Q1 		$1.23M Sell
12,884
-7,828
-38% -$714K 0.01% 801
2020
Q4 		$1.64M Sell
20,712
-16,788
-45% -$1.22M 0.01% 732
2020
Q3 		$2.32M Buy
37,500
+1,512
+4% +$98.4K 0.01% 673
2020
Q2 		$2.38M Sell
35,988
-43,040
-54% -$2.58M 0.01% 595
2020
Q1 		$3.75M Buy
79,028
+44,340
+128% +$2.22M 0.03% 515
2019
Q4 		$1.9M Buy
+34,688
New +$1.82M 0.01% 771

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Aviva's TECH Position: Q3 2025 in Review

Aviva sold out of Bio-Techne (TECH) in Q3 2025, closing a stake of 5,739 shares — an estimated $295K sold.

Aviva first reported a position in TECH in Q4 2019 and held it in 23 quarters. The position peaked at $11.8M in Q1 2023. 577 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

  • Aviva reported no remaining Bio-Techne position as of Q3 2025 after selling out during the quarter.
  • Aviva sold 5,739 Bio-Techne shares in Q3 2025, an estimated $295K.
  • Aviva first reported a position in Bio-Techne in Q4 2019 and held it in 23 quarters.
  • Aviva's Bio-Techne position peaked at $11.8M in Q1 2023.
  • 577 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on Aviva's 13F filing for Q3 2025, filed 13 Nov 2025.